E-cigarettes may promote illicit drug use and addiction

Key points
- "While e-cigarettes do eliminate some of the health effects associated with combustible tobacco, they are pure nicotine-delivery devices," said co-author Denise B.
- Columbia Psychiatry is ranked among the best academic departments and psychiatric research facilities in the nation and has contributed greatly to the understanding and treatment of psychiatric disorders.
- Zuckerman Mind Brain Behavior Institute is an interdisciplinary hub for scholars across the university, created on a scope and scale to explore the human brain and behavior at levels of inquiry from cells to society.
- Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care.
Like conventional cigarettes, electronic cigarettes (or e-cigarettes) may function as a "gateway drug" - a drug that lowers the threshold for addiction to other substances, such as marijuana and cocaine - according to the 120th Shattuck lecture, presented to the Massachusetts Medical Society by Columbia researchers Denise and Eric Kandel and published today in the online edition of the New England Journal of Medicine.
"While e-cigarettes do eliminate some of the health effects associated with combustible tobacco, they are pure nicotine-delivery devices," said co-author Denise B. Kandel, PhD, professor of sociomedical sciences (in psychiatry), Department of Psychiatry and Mailman School of Public Health, at Columbia University Medical Center (CUMC).
The other co-author of the Shattuck lecture is Eric R. Kandel, MD, University Professor and Kavli Professor of Brain Science, co-director of the Mortimer B. Zuckerman Mind Brain Behavior Institute, director of the Kavli Institute for Brain Science, and senior investigator of the Howard Hughes Medical Institute at CUMC. Dr. Kandel shared the 2000 Nobel Prize in Physiology or Medicine for his discoveries related to the molecular basis of memory.
In the lecture, the Kandels review Denise Kandel's earlier work on the gateway hypothesis and on the role of nicotine as a gateway drug, reported in a Science paper in l975.
They also review subsequent studies in which they tested the gateway hypothesis experimentally in a mouse model. In those studies, conducted in collaboration with Amir Levine, Yan You Huang, Bettina Drisaldi, Edmund A Griffin, and others at CUMC, they found that when mice are exposed to nicotine, it alters their brain biochemically and induces activation of a reward-related gene. As a result, nicotine primes the animals' subsequent response to cocaine, providing a molecular basis for nicotine as a gateway drug for cocaine.
Dr. Denise Kandel's further analysis of 2004 epidemiologic data from a large, longitudinal sample suggested that nicotine also primes human brains to respond to cocaine. She found that the rate of cocaine dependence was highest among users who started using cocaine after having smoked cigarettes. "Our findings provided a biologic basis for the sequence of drug use observed in people," said Dr. Eric Kandel. "One drug alters the brain's circuitry in a way that enhances the effects of a subsequent drug."
E-cigarettes have been touted as a tool to curtail the use of conventional cigarettes and reduce the harmful health effects of combustible tobacco. But in light of the skyrocketing popularity of e-cigarettes, particularly among adolescents and young adults, the researchers say that more effective prevention programs need to be developed for all products that contain nicotine.
"E-cigarettes have the same physiological effects on the brain and may pose the same risk of addiction to other drugs as regular cigarettes, especially in adolescence during a critical period of brain development. We don't yet know whether e-cigarettes will prove to be a gateway to the use of conventional cigarettes and illicit drugs, but that's certainly a possibility. Nicotine clearly acts as a gateway drug on the brain, and this effect is likely to occur whether the exposure comes from smoking cigarettes, passive tobacco smoke, or e-cigarettes."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsArmy drug users twice as likely to use synthetic marijuana as regular marijuana
Social work researchers from the University of Washington have found that among a group of active-duty Army personnel who use illicit drugs, the most abused substance is synthetic marijuana, which is harder to detect…
9 May 2014
NewsU.S. city health officials want tighter restrictions on e-cigarettes
A group of urban health officials on Thursday urged the Food and Drug Administration to go beyond the regulations it proposed last week for e-cigarettes and treat them like regular cigarettes. In an open letter to FDA…
2 May 2014
NewsFDA rejects wider use of Xarelto drug
U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday. The companies had sought approval from…